DSNKY Projected Dividend Yield
ADR Level 1 (Sponsored)/Daiichi Sankyo Co Ltd ( OTCBB : DSNKY )Daiichi Sankyo is mainly engaged in the research, development, manufacture, sale and marketing of pharmaceutical products. Co. offers prescription drugs, including "ENHERTU" for cancer treatments, anticoagulants "LIXIANA/SAVAYSA," antihypertensive agents "MINNEBRO," antipatelet agents "EFFIENT," "CANALLIA" for type 2 diabetes mellitus, "Injectafer" for iron deficiency anemia and "NEXIUM" for ulcers treatments, as well as influenza vaccines, measles/rubella vaccines and mumps vaccines. Co also manufactures over-the-counter drugs, cosmetics and medical equipment. Co. operates its business activities in Japan, the Americas, Europe, China and Asia. 25 YEAR PERFORMANCE RESULTS |
DSNKY Dividend History Detail DSNKY Dividend News DSNKY Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
2024 |
N/A |
N/A |
Sep 30, 2024 |
Dec 17, 2024 |
0.1966 |
2024 |
N/A |
N/A |
Mar 28, 2024 |
Jun 25, 2024 |
0.1901 |
2024 Total: |
0.3867 |
||||
2023 |
N/A |
N/A |
Sep 29, 2023 |
Dec 15, 2023 |
0.1383 |
2023 |
N/A |
N/A |
Mar 31, 2023 |
Jun 27, 2023 |
0.1061 |
2023 Total: |
0.2444 |
||||
2022 |
N/A |
N/A |
Sep 30, 2022 |
Dec 08, 2022 |
0.1104 |
2022 |
N/A |
N/A |
Mar 31, 2022 |
Jul 05, 2022 |
0.0991 |
2022 Total: |
0.2095 |
||||
2021 |
N/A |
N/A |
Sep 29, 2021 |
Dec 09, 2021 |
0.1194 |
2021 |
N/A |
N/A |
Mar 30, 2021 |
Jun 29, 2021 |
0.1221 |
2021 Total: |
0.2415 |
||||
2020 |
N/A |
N/A |
Sep 29, 2020 |
Dec 08, 2020 |
0.1293 |
2020 |
N/A |
N/A |
Mar 30, 2020 |
Jun 23, 2020 |
0.1086 |
2020 Total: |
0.2379 |
||||
2019 |
N/A |
N/A |
Sep 27, 2019 |
Dec 10, 2019 |
0.1075 |
2019 |
N/A |
N/A |
Mar 29, 2019 |
Jun 26, 2019 |
0.1075 |
2019 Total: |
0.2150 |